W
ABBV icon

Wealthfront’s AbbVie ABBV Stock Holding History

Wealthfront’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$5.33M Sell
56,322
-10,036
-15% -$952K 0.05% 57
2018
Q2 		$6.15M Sell
66,358
-13,248
-17% -$1.29M 0.06% 49
2018
Q1 		$7.54M Sell
79,606
-551
-0.7% -$60.5K 0.08% 43
2017
Q4 		$7.75M Buy
80,157
+10,215
+15% +$963K 0.09% 38
2017
Q3 		$6.21M Buy
69,942
+7,875
+13% +$599K 0.08% 41
2017
Q2 		$4.5M Buy
62,067
+10,832
+21% +$728K 0.07% 52
2017
Q1 		$3.34M Buy
51,235
+1,751
+4% +$110K 0.06% 62
2016
Q4 		$3.1M Buy
49,484
+5,626
+13% +$343K 0.07% 51
2016
Q3 		$2.77M Buy
43,858
+4,228
+11% +$274K 0.07% 57
2016
Q2 		$2.45M Buy
39,630
+6,293
+19% +$383K 0.07% 55
2016
Q1 		$1.9M Buy
33,337
+14,280
+75% +$796K 0.06% 62
2015
Q4 		$1.13M Buy
19,057
+4,873
+34% +$281K 0.04% 79
2015
Q3 		$772K Sell
14,184
-5,145
-27% -$335K 0.03% 94
2015
Q2 		$1.3M Buy
19,329
+10,021
+108% +$654K 0.05% 45
2015
Q1 		$545K Sell
9,308
-622
-6% -$37.6K 0.03% 78
2014
Q4 		$650K Buy
9,930
+2,815
+40% +$177K 0.04% 56
2014
Q3 		$411K Buy
7,115
+2,284
+47% +$127K 0.03% 67
2014
Q2 		$281K Buy
4,831
+1,549
+47% +$81.3K 0.02% 72
2014
Q1 		$171K Buy
+3,282
New +$166K 0.02% 68

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wealthfront's ABBV Position: Q3 2018 in Review

Wealthfront reduced its AbbVie (ABBV) stake by 15% in Q3 2018, selling an estimated $952K and leaving 56,322 shares worth $5.33M. The position accounts for 0.05% of the portfolio, ranked #57.

Wealthfront first reported a position in ABBV in Q1 2014 and has held it in 19 quarters since. The position peaked at $7.75M in Q4 2017. 1,957 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

  • Wealthfront held 56,322 shares of AbbVie worth $5.33M as of Q3 2018.
  • Wealthfront sold 10,036 AbbVie shares in Q3 2018, an estimated $952K.
  • AbbVie made up 0.05% of Wealthfront's portfolio in Q3 2018, its #57 holding.
  • Wealthfront first reported a position in AbbVie in Q1 2014 and has held it in 19 quarters since.
  • Wealthfront's AbbVie position peaked at $7.75M in Q4 2017.
  • 1,957 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.